Ingalls & Snyder LLC’s Gilead Sciences GILD Stock Holding History

Ingalls & Snyder LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,100	Closed	-$623K	–	446
2022 Q3	$623K	Hold	10,100	–	–	0.03%	244
2022 Q2	$624K	Hold	10,100	–	–	0.03%	252
2022 Q1	$600K	Hold	10,100	–	–	0.03%	285
2021 Q4	$733K	Hold	10,100	–	–	0.03%	264
2021 Q3	$705K	Hold	10,100	–	–	0.03%	271
2021 Q2	$695K	Buy	10,100 +4,500	+80%	+$300K	0.03%	274
2021 Q1	$362K	Buy	5,600 +4,100	+273%	+$264K	0.02%	335
2020 Q4	$87K	Buy	+1,500	New	+$90.5K	﹤0.01%	416
2018 Q4	–	Sell	-9,600	Closed	-$741K	–	424
2018 Q3	$741K	Hold	9,600	–	–	0.03%	266
2018 Q2	$680K	Hold	9,600	–	–	0.03%	243
2018 Q1	$724K	Hold	9,600	–	–	0.04%	235
2017 Q4	$688K	Buy	+9,600	New	+$729K	0.03%	249
2017 Q3	–	Sell	-9,600	Closed	-$679K	–	371
2017 Q2	$679K	Hold	9,600	–	–	0.04%	218
2017 Q1	$652K	Hold	9,600	–	–	0.03%	232
2016 Q4	$687K	Buy	+9,600	New	+$714K	0.04%	230
2016 Q3	–	Sell	-8,600	Closed	-$717K	–	422
2016 Q2	$717K	Buy	+8,600	New	+$763K	0.04%	218

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ingalls & Snyder LLC's GILD Position: Q4 2022 in Review

Ingalls & Snyder LLC sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 2,255 shares — an estimated $139K sold.

Ingalls & Snyder LLC first reported a position in GILD in Q2 2014 and held it in 33 quarters. The position peaked at $18.7M in Q2 2015. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

Ingalls & Snyder LLC reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
Ingalls & Snyder LLC sold 2,255 Gilead Sciences shares in Q4 2022, an estimated $139K.
Ingalls & Snyder LLC first reported a position in Gilead Sciences in Q2 2014 and held it in 33 quarters.
Ingalls & Snyder LLC's Gilead Sciences position peaked at $18.7M in Q2 2015.
1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2022, filed 31 Jan 2023.